LGALS4 and central nervous system cancer: We excluded the possibility that suppression of TM expansion and glioma progression was due to a titration of GAL4 activity caused by introducing an additional UAS-transgene (UAS-lacZ or UAS-yellow-RNAi; S2A and S2B Fig).